Potential Protective Effect of Honey Against Paracetamol-Induced
Hepatotoxicity
Arch Iran Med, 2012 Nov;15(11):674-80
BACKGROUND:
Paracetamol overdose causes severe hepatotoxicity that leads
to liver failure in both humans and experimental animals. The present study
investigates the protective effect of honey against paracetamol-induced
hepatotoxicity in Wistar albino rats. We have used silymarin as a standard
reference hepatoprotective drug.
METHODS:
Hepatoprotective activity was assessed by measuring
biochemical parameters such as the liver function enzymes, serum alanine
aminotransferase (ALT) and serum aspartate aminotransferase (AST). Equally,
comparative effects of honey on oxidative stress biomarkers such as
malondialdyhyde (MDA), reduced glutathione (GSH) and glutathione peroxidase
(GPx) were also evaluated in the rat liver homogenates. We estimated the effect of honey on serum
levels and hepatic content of interleukin-1beta (IL-1β) because the initial
event in paracetamol-induced hepatotoxicity has been shown to be a
toxic-metabolic injury that leads to hepatocyte death, activation of the innate
immune response and upregulation of inflammatory cytokines.
RESULTS:
Paracetamol caused marked liver damage as noted by
significant increased activities of serum AST and ALT as well as the level of
Il-1β. Paracetamol also resulted in a significant decrease in liver GSH content
and GPx activity which paralleled an increase in Il-1β and MDA levels. Pretreatment
with honey and silymarin prior to the administration of paracetamol
significantly prevented the increase in the serum levels of hepatic enzyme
markers, and reduced both oxidative stress and inflammatory cytokines.
Histopathological evaluation of the livers also revealed that honey reduced the
incidence of paracetamol-induced liver lesions.
CONCLUSION:
Honey can be used as an effective hepatoprotective agent
against paracetamol-induced liver damage.